Skip to main content

Aplastic Anemia Clinical Trials

Review the aplastic anemia clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-9 of 9

Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
Status: Active
Location: 22 locations
Emapalumab for the Treatment of Pediatric Patients with Aplastic Anemia
Status: Active
Location: 11 locations
Hematopoietic Cell Transplant with Individualized Reduced Intensity Conditioning and Post-Transplant Cyclophosphamide for the Treatment of Patients with Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients with Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Status: Active
Location: Saint Jude Children's Research Hospital, Memphis, Tennessee
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Status: Active
Location: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients who Undergo a Hematopoietic Stem Cell Transplant
Status: Temporarily Closed to Accrual
Location: Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Status: Active
Location: See ClinicalTrials.gov